Analysis of Factors Associated With Interstitial Lung Disease in Treatment-Naïve Rheumatoid Arthritis Patients and Development of a Classification Nomogram.
- 1Department of Rheumatology and Immunology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Abstract
Background
Interstitial lung disease (ILD) is a serious extra-articular manifestation of rheumatoid arthritis (RA) and contributes substantially to morbidity and mortality. Early identification of RA-associated ILD (RA-ILD) remains challenging, and reliable biomarkers for risk stratification are lacking.Objective
This study aimed to identify cytokine-related factors associated with RA-ILD and to develop an exploratory classification model for assessing the presence of ILD in patients with newly diagnosed, treatment-naïve RA.Methods
A total of 66 newly diagnosed, treatment-naïve RA patients were enrolled, including individuals with and without ILD confirmed by high-resolution computed tomography (HRCT). All patients were disease-modifying antirheumatic drug (DMARD)-naïve and had not received glucocorticoids or biologics prior to enrollment. Plasma IL-22 concentration was measured by ELISA; other cytokines (IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A, IFN-γ, and TNF-α) were quantified using a multiplex bead-based immunoassay. Clinical characteristics, laboratory parameters, and radiological findings were collected. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression and Boruta algorithms, followed by multivariable logistic regression to identify independent factors associated with RA-ILD. A nomogram was constructed based on selected predictors, and its performance was evaluated using receiver operating characteristic analysis and cross-validation.Results
Patients with RA-ILD exhibited distinct cytokine profiles compared with those without ILD. Multivariable analysis identified age, smoking, lower mean corpuscular hemoglobin concentration (MCHC), higher plasma TNF-α levels and lower plasma IL-22 levels as independent factors associated with RA-ILD. The nomogram exhibited good discriminative performance, with a fivefold cross-validated AUC of 0.851 (95% CI: 0.755-0.947); the apparent AUC in the full sample was 0.87. Internal validation indicated acceptable model stability.Conclusion
Age, smoking, MCHC, higher plasma TNF-α levels and lower plasma IL-22 levels were associated with the presence of ILD in newly diagnosed, treatment-naïve RA patients. The proposed cytokine-based nomogram may serve as a hypothesis-generating tool for early identification of RA-ILD. Further validation in larger, independent cohorts is warranted before clinical application.
Related
- Granulomatous Interstitial Nephritis Associated With Adalimumab Therapy in a Patient With Rheumatoid Arthritis: A Case Report
- Screening for rheumatoid arthritis-associated interstitial lung disease using lung ultrasound: a systematic review and quality appraisal of recent studies
- Lung Ultrasound in Rheumatoid Arthritis–Associated Interstitial Lung Disease: Association with Radiological Patterns, Lung Function Tests, and Disease Activity—A Single-Center Retrospective Cross-Sectional Study
- Contemporary Guideline Perspectives on Methotrexate and Biologic/Targeted Synthetic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis-Associated Interstitial Lung Disease
- Real-world association of biologic and targeted synthetic DMARD use with mortality in rheumatoid arthritis-associated interstitial lung disease: a nationwide cohort study
BibTeX
@article{lu2026analysis,
title = {{Analysis of Factors Associated With Interstitial Lung Disease in Treatment-Naïve Rheumatoid Arthritis Patients and Development of a Classification Nomogram.}},
author = {Li Lu and Yongkang Chen and Ting Zhang and Lina Cao and Hua Ma and Yuanyuan Song and Dongmei Zhou},
journal = {Immunity, inflammation and disease},
year = {2026},
month = oct,
doi = {10.1002/iid3.70571},
url = {https://europepmc.org/article/MED/42958640},
note = {CC BY},
}
RIS
TY - JOUR
TI - Analysis of Factors Associated With Interstitial Lung Disease in Treatment-Naïve Rheumatoid Arthritis Patients and Development of a Classification Nomogram.
AU - Li Lu
AU - Yongkang Chen
AU - Ting Zhang
AU - Lina Cao
AU - Hua Ma
AU - Yuanyuan Song
AU - Dongmei Zhou
PY - 2026
DA - 2026/10/01
JO - Immunity, inflammation and disease
DO - 10.1002/iid3.70571
UR - https://europepmc.org/article/MED/42958640
AB - Background Interstitial lung disease (ILD) is a serious extra-articular manifestation of rheumatoid arthritis (RA) and contributes substantially to morbidity and mortality. Early identification of RA-associated ILD (RA-ILD) remains challenging, and reliable biomarkers for risk stratification are lacking.Objective This study aimed to identify cytokine-related factors associated with RA-ILD and to develop an exploratory classification model for assessing the presence of ILD in patients with newly diagnosed, treatment-naïve RA.Methods A total of 66 newly diagnosed, treatment-naïve RA patients were enrolled, including individuals with and without ILD confirmed by high-resolution computed tomography (HRCT). All patients were disease-modifying antirheumatic drug (DMARD)-naïve and had not received glucocorticoids or biologics prior to enrollment. Plasma IL-22 concentration was measured by ELISA; other cytokines (IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A, IFN-γ, and TNF-α) were quantified using a multiplex bead-based immunoassay. Clinical characteristics, laboratory parameters, and radiological findings were collected. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression and Boruta algorithms, followed by multivariable logistic regression to identify independent factors associated with RA-ILD. A nomogram was constructed based on selected predictors, and its performance was evaluated using receiver operating characteristic analysis and cross-validation.Results Patients with RA-ILD exhibited distinct cytokine profiles compared with those without ILD. Multivariable analysis identified age, smoking, lower mean corpuscular hemoglobin concentration (MCHC), higher plasma TNF-α levels and lower plasma IL-22 levels as independent factors associated with RA-ILD. The nomogram exhibited good discriminative performance, with a fivefold cross-validated AUC of 0.851 (95% CI: 0.755-0.947); the apparent AUC in the full sample was 0.87. Internal validation indicated acceptable model stability.Conclusion Age, smoking, MCHC, higher plasma TNF-α levels and lower plasma IL-22 levels were associated with the presence of ILD in newly diagnosed, treatment-naïve RA patients. The proposed cytokine-based nomogram may serve as a hypothesis-generating tool for early identification of RA-ILD. Further validation in larger, independent cohorts is warranted before clinical application.
SN - 2050-4527
ER -